ELK1 and cervical carcinoma: H-rev107 forms a complex with H-RAS and reduces the palmitoylation level of H-RAS. In HtTA cervical cancer cells, H-rev107 lowers the levels of activated RAS (RAS-GTP) and decreases ELK1-mediated transactivation.